Abstract

Phosphine-borane complexes are novel chemical entities with preclinical efficacy in neuronal and ophthalmic disease models. In vitro and in vivo studies showed that the metabolites of these compounds are capable of cleaving disulfide bonds implicated in the downstream effects of axonal injury. A difficulty in using standard in silico methods for studying these drugs is that most computational tools are not designed for borane-containing compounds. Using in silico and machine learning methodologies, the absorption-distribution properties of these unique compounds were assessed. Features examined with in silico methods included cellular permeability, octanol-water partition coefficient, blood-brain barrier permeability, oral absorption and serum protein binding. The resultant neural networks demonstrated an appropriate level of accuracy and were comparable to existing in silico methodologies. Specifically, they were able to reliably predict pharmacokinetic features of known boron-containing compounds. These methods predicted that phosphine-borane compounds and their metabolites meet the necessary pharmacokinetic features for orally active drug candidates. This study showed that the combination of standard in silico predictive and machine learning models with neural networks is effective in predicting pharmacokinetic features of novel boron-containing compounds as neuroprotective drugs.

Highlights

  • Published: 25 April 2021Neurodegenerative diseases affecting the optic nerve are a common cause of visual loss [1,2]

  • According to the Maestro knowledge base greater than 80% is considered high absorption and lower than 20% is considered low absorption [16]. These findings suggest that phosphine-borane compounds are predicted to passively cross the gut-blood barrier [13]

  • The compounds compounds sary were able able to to moderately traverse passively passively the the cell where the were moderately traverse cell membrane, membrane, where the deboronated deboronated non-oxidized phosphines traverse the fastest. This indicates that the active drug. This indicates that the active drug of cleaving disulfide bonds) can enter cells

Read more

Summary

Introduction

Published: 25 April 2021Neurodegenerative diseases affecting the optic nerve are a common cause of visual loss [1,2]. Axonal damage induces RGC somatic death via a variety of mechanisms, including signaling via reactive oxygen species (ROS), superoxide, based on studies increased levels in neurons after injury and that ROS scavengers prevent RGC death [4,5]. One mechanism for ROS signaling is that highly oxidative environments increase the formation of disulfide bonds between cystine side chains and cause cellular damage [6,7,8]. Support for this mechanism is based on the neuroprotective properties of disulfide reducing agents both in vitro and in vivo [6,7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call